In this trial, we will be evaluating the safety and effect of copanlisib on survival of dogs with splenic hemangiosarcoma
clinical trial Mason Active hemangiosarcoma cancer Brian Flesner active
T cell therapy for drug resistant B cell Lymphoma
Mason Active lymphoma dogs canine cancer active cancer B-cell lymphoma active
NBD Peptide for Soft Tissue Sarcoma
Mason Active tumor soft tissue sarcoma sarcoma mass cancer center Cancer Care cancer active
Immune cells (known as T cells) are taken from the peripheral blood, stimulated, expanded and genetically modified in the laboratory to express a surface receptor that recognizes B cells
Mason Active immunotherapy comprehensive cancer care canine lymphoma canine cancer cancer center cancer active cancer b-cell malignancies B-cell lymphoma active
